Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses. - Wikidata - awgldk - TriplyDB

Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.

Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.

http://www.wikidata.org/entity/Q33419836

about

Influenza: the once and future pandemic A highly conserved neutralizing epitope on group 2 influenza A viruses Structural characterization of viral epitopes recognized by broadly cross-reactive antibodies Universal immunity to influenza must outwit immune evasion H5N1 vaccines in humans Broadly neutralizing antibodies against influenza virus and prospects for universal therapies Significant impact of sequence variations in the nucleoprotein on CD8 T cell-mediated cross-protection against influenza A virus infections Monoclonal antibody-based therapies for microbial diseases A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins Cross-neutralization of influenza A viruses mediated by a single antibody loop Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity Influenza Human Monoclonal Antibody 1F1 Interacts with Three Major Antigenic Sites and Residues Mediating Human Receptor Specificity in H1N1 Viruses A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin Conserved Neutralizing Epitope at Globular Head of Hemagglutinin in H3N2 Influenza Viruses Two Escape Mechanisms of Influenza A Virus to a Broadly Neutralizing Stalk-Binding Antibody An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli Large-scale analysis of B-cell epitopes on influenza virus hemagglutinin - implications for cross-reactivity of neutralizing antibodies.Rapid Generation of Human-Like Neutralizing Monoclonal Antibodies in Urgent Preparedness for Influenza Pandemics and Virulent Infectious Diseases.One step closer to universal influenza epitopes.Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections.Continuing challenges in influenza.Diversity of the murine antibody response targeting influenza A(H1N1pdm09) hemagglutinin Adenoviral vectors as novel vaccines for influenza.An anti-H5N1 influenza virus FcDART antibody is a highly efficacious therapeutic agent and prophylactic against H5N1 influenza virus infection Human monoclonal antibodies targeting the haemagglutinin glycoprotein can neutralize H7N9 influenza virus.Serum Samples From Middle-aged Adults Vaccinated Annually with Seasonal Influenza Vaccines Cross-neutralize Some Potential Pandemic Influenza Viruses.Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses.The Analysis of B-Cell Epitopes of Influenza Virus Hemagglutinin.Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine Specific recognition of influenza A/H1N1/2009 antibodies in human serum: a simple virus-free ELISA method.Intranasal delivery of an IgA monoclonal antibody effective against sublethal H5N1 influenza virus infection in mice A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection.Human monoclonal antibodies broadly neutralizing against influenza B virus.Pandemic influenza 1918 H1N1 and 1968 H3N2 DNA vaccines induce cross-reactive immunity in ferrets against infection with viruses drifted for decades.Hallmarks of CD4 T cell immunity against influenza Identification of a highly conserved H1 subtype-specific epitope with diagnostic potential in the hemagglutinin protein of influenza A virus.Targets for the induction of protective immunity against influenza a viruses.A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses.New technologies for influenza vaccines.Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses

P2860

Q24630177-B2264128-08B5-4E5E-8A82-CDDD5ACFF20F Q24630467-B9CA2EEA-3796-4339-A729-C12D27561F4F Q26823492-5D57480A-6FDF-471A-86D8-07D9BB5B4FC7 Q26991896-E9980CA2-7877-4BAF-A75C-A18AD40FDFF9 Q27000896-C0AA06DA-DE61-4D05-ACD6-D2F0B59A76DD Q27010503-1C59E975-861C-4393-8ADD-B95694FE665D Q27329554-36B5AB46-0597-4624-BD43-882FFD3B400C Q27490830-ACB5C435-4640-4F57-97DC-729E2C2344DF Q27671165-D9541BB6-D354-4885-BC89-C01A0F23F5AF Q27673206-C2654CF9-CD9A-40D6-9C32-073953D2BF33 Q27673861-62E7CF06-7065-44B7-B0B4-5F3C8EB07769 Q27675477-214D7151-2AC9-4C67-97A8-F050DD73B490 Q27676298-94B6BA67-8B88-4D44-9381-4D7509CFEAC5 Q27683198-43068F4E-730F-4701-AEFD-05E90256B959 Q28552195-0C897BCD-89A6-42E4-82DF-C818753FED22 Q28750246-5DC61469-73D2-4D0F-A41E-2D0F17F97C27 Q30217235-E446C93F-8543-4D16-BAB0-7EC538D8C9A8 Q30222441-27E14BAD-E989-4B62-BE53-9A585681B91D Q30227646-8AAA1B09-D188-4B50-8C26-03AD808C59E0 Q30358388-B91691F7-F960-4E49-B6B6-58ED7354D075 Q30363190-D59BE7DE-2EB2-4BE4-BA0B-0D0CDF82FA02 Q30363595-BA261014-2D1C-4F1B-83C9-F0BBC66AAD25 Q30370445-2C8D6B8F-4B75-417B-911D-A9AEA15A7E52 Q30371674-1CE941F1-318A-497D-B02D-6CF94FC57527 Q30373175-0918C09A-2F81-4323-8721-2628C2C67F9B Q30377531-0B4254B8-D8D6-4868-98E9-C516C88FD8C4 Q30383987-995BAC11-89F3-43A1-BA2D-90EA28870D5E Q30387177-2C448E5D-3BF8-4148-B35B-29212FC7902A Q30388038-539A7F38-6197-4C2E-973C-06E5DAE4DABC Q30388531-AE2D5D64-CDDC-4ED4-99C2-05286F03D306 Q30391974-D60A25B3-140C-492A-9C3A-F15A05A78BF0 Q30393843-7989E29E-2F8D-471E-98F2-CFA89A4B68CF Q30394240-A822B950-F0FD-401A-85CB-C72E591591F2 Q30397107-86FC18FF-4F25-44CA-A132-94BEB2D98D42 Q30400290-C93F9BEC-1959-446F-AB0C-0C952DE25423 Q30406634-B4056C04-EC02-4B00-AA87-6D71D8BB30CB Q30408100-36F67144-2210-4791-A27A-9403022C0D6F Q30411637-369BD89E-E48E-4F6A-9458-AC557F904999 Q30411859-B1E66188-820D-447C-A69A-F5632A667FEA Q30414712-42D9AAAB-DCC2-452A-B36F-E9144D23DEDF

P2860

Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses.

http://www.wikidata.org/entity/Q33419836

description

2009 nî lūn-bûn

@nan

2009 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մարտին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Cross-protective potential of ...... utinin of influenza A viruses.

@ast

Cross-protective potential of ...... utinin of influenza A viruses.

@en

type

label

Cross-protective potential of ...... utinin of influenza A viruses.

@ast

Cross-protective potential of ...... utinin of influenza A viruses.

@en

prefLabel

Cross-protective potential of ...... utinin of influenza A viruses.

@ast

Cross-protective potential of ...... utinin of influenza A viruses.

@en

P1433

Q33419836-3212EF90-7FCC-4067-9A39-658CAA07AC4E

P1476

Q33419836-3D86D4DC-CB9D-47B0-9C27-74B83F83B91F

P2093

Q33419836-063FE680-B2BB-4A3A-863E-16FB47C874AF

Q33419836-095052A0-D9B8-445D-8329-C141955FFCAE

Q33419836-27494099-D522-4415-B9EB-BC69338B9641

Q33419836-27DA414A-EA16-41C6-B2CB-3CF67866FD04

Q33419836-2C315B66-E0E3-49EE-BE9B-B2B7DE1FC465

Q33419836-4E64CE97-6BA3-422B-99FB-C0B88659B8DB

Q33419836-CF6CA68F-4BE7-4755-990B-2A5F18EF6D23

P2860

Q33419836-0ABE3D17-8A6E-43C8-802C-D3319B1C41F6

Q33419836-0CAF71CF-100D-4AB7-9558-B64A085E7A57

Q33419836-0F52B3E7-0B2D-4EB3-9445-E652475DA716

Q33419836-107BF4D6-BADF-43C2-ABD2-86B6B96C65DD

Q33419836-12E4751D-B4B6-40C3-8320-0B40CBFE0E6A

Q33419836-179A57B8-64A6-4469-A44E-A43CFD3329A1

Q33419836-1E153BDC-037B-4271-879A-1FD9BF072596

Q33419836-25D578DF-6713-4E58-B0FB-1C9CF5BB2A89

Q33419836-2A2965A4-AFE6-4333-AAC1-BBA23EB04C2C

Q33419836-2F53D1CF-24B6-4005-A119-8FAE82803963

P304

Q33419836-EF2FF2F7-3980-495C-82D1-F6DE863F9BCF

P31

Q33419836-0972F3E8-B5C3-4162-A561-EAA6DC73992D

P356

Q33419836-17E3C105-5666-48ED-BC5E-C0300EC8293F

P433

Q33419836-DFA797DB-8045-4A56-B6C5-4E486CA53D3A

P478

Q33419836-F26B201A-4A77-40A6-A84A-84A4B409BBC1

P50

Q33419836-6E161284-264C-43E3-96F5-F39E18849E59

P577

Q33419836-B0765D21-4AD0-4EA4-ADA3-7E7400FC0F24

P5875

Q33419836-D83FE76B-7229-4589-B810-6117740F4332

P698

Q33419836-4CCF52BC-9FE9-42FB-ABA4-9D02F430AAC1

P921

Q33419836-CC0DD143-A4E8-4ABC-A30F-2C961D4A8034

P932

Q33419836-FEC3D022-D13F-4309-9CAC-BD298955DA48

P356

JOURNAL.PPAT.1000350

P1433

P1476

Cross-protective potential of ...... utinin of influenza A viruses.

@en

P2093

Ayato Takada

http://www.w3.org/2001/XMLSchema#string

Daisuke Tomabechi

http://www.w3.org/2001/XMLSchema#string

Hiroichi Ozaki

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kida

http://www.w3.org/2001/XMLSchema#string

Manabu Igarashi

http://www.w3.org/2001/XMLSchema#string

Noriko Kishida

http://www.w3.org/2001/XMLSchema#string

Reiko Yoshida

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls

Evolution and ecology of influenza A viruses

PROCHECK: a program to check the stereochemical quality of protein structures

A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site

X-ray structure of the hemagglutinin of a potential H3 avian progenitor of the 1968 Hong Kong pandemic influenza virus

The structure and receptor binding properties of the 1918 influenza hemagglutinin

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution

VERIFY3D: assessment of protein models with three-dimensional profiles

Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals

P304

e1000350

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.1000350

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24214247

http://www.w3.org/2001/XMLSchema#string

P698

19300497

http://www.w3.org/2001/XMLSchema#string

P921

P932

2652660

http://www.w3.org/2001/XMLSchema#string